Home page

SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit developed by Nanjing Synthgene Medical was successfully registered with the National Medical Products Administration of Ukraine

SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit developed by Nanjing Synthgene Medical was successfully registered with the National Medical Products Administration of Ukraine

SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit developed by Nanjing Synthgene Medical was successfully registered with the National Medical Products Administration of Ukraine.

29

2021

/

10

In the post-epidemic era of the blue ocean market--POC, Screen, Home Testing，Nanjing Synthgene Medical accelerates product line distribution!

In the post-epidemic era of the blue ocean market--POC, Screen, Home Testing，Nanjing Synthgene Medical accelerates product line distribution!

Since the beginning of this year, the global COVID-19 epidemic has not slowed down due to the rapid vaccination of the vaccine. The global anti-epidemic situation is still severe. Different countries are experiencing the second, third or fourth peak. Statistics show that Until October 24, 2021, the cumulative number of reported cases of new COVID-19 infection worldwide has exceeded 240 million. The new COVID-19 anti-epidemic will be a protracted battle in the world!

24

2021

/

10

New Product Launch SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit(Colloidal gold method)—Lollipop style

New Product Launch SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit(Colloidal gold method)—Lollipop style

Since the beginning of this year, the global situation of the new crown epidemic remains severe, and the fight against the new crown epidemic will be a protracted global battle. In this context, the demand for new coronavirus diagnostic kits in the world continues to remain high, and the demand for antigen kits in particular will show a significant upward trend in 2021.

19

2021

/

10

SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit developed by Nanjing Synthgene Medical enters the whitelist of French COVID-19 detection products

SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit developed by Nanjing Synthgene Medical enters the whitelist of French COVID-19 detection products

On October 12, SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit(Colloidal gold method) developed by Nanjing Synthgene Medical enters the whitelist of French COVID-19 detection products

12

2021

/

10

Nanjing Synthgene Medical COVID -19 Antigen detection kit passed the laboratory test of Mahidol University in Thailand

Nanjing Synthgene Medical COVID -19 Antigen detection kit passed the laboratory test of Mahidol University in Thailand

Today, Nanjing Synthgene Medical’s SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit (Colloidal gold method) Salivary was tested in the laboratory of Mahidol University in Thailand, and the test results showed 96.67% high sensitivity and 100% specificity, the quality of Nanjing Synthgene Medical products is highly recognized by the laboratory of Mahidol University in Thailand.

08

2021

/

10

< 1...15 16 17 18 >

Nanjing Synthgene Medical Technology Co., Ltd.

Nanjing Synthgene Medical Technology Co., Ltd. is a biomedical high-tech enterprise focusing on the development and production of OTC home self-inspection products. The company has a mature technology platform, including chromatography platform, isothermal amplification platform, etc.

Messages

Messages

whatsapp

whatsapp

E-mail

E-mail

TOP

Contact Us

Address：Building B6-2, No. 9, Weidi Road, Xianlin University Town, Xianlin Subdistrict, Qixia District, Nanjing City, China

Email: info@syngenebio.com

After-sale Email ： service@syngenebio.com

Copyright © Nanjing Synthgene Medical Technology Co., Ltd. | SEO | Powered by： www.300.cn

Business License

Close

Inquiry

Total X Clear all